Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone

Neha Korde, Donna Mastey, Elizabet Tavitian, Sham Mailankody, Alexander Lesokhin, Hani Hassoun, Eric L. Smith, Nikoletta Lendvai, Malin Hultcrantz, Urvi Shah, Carlyn Tan, Sydney Lu, Benjamin Diamond, Meghan Salcedo, Kelly Werner, David J. Chung, Michael Scordo, Gunjan L. Shah, Oscar Lahoud, Heather LandauMaria Arcila, Caleb Ho, Mikhail Roshal, Ahmet Dogan, Andriy Derkach, Sean M. Devlin, Sergio A. Giralt, Ola Landgren

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)E193-E196
JournalAmerican Journal of Hematology
Volume96
Issue number6
DOIs
StatePublished - Jun 1 2021

ASJC Scopus subject areas

  • Hematology

Cite this